Sabine Luik, MD, MBA is a non-executive director at Kanna Health. She also currently serves as Director at ViiV Healthcare. In December 2018, Sabine was appointed Chief Medical Officer and Senior Vice President, Global Medical, Regulatory and Quality at GSK, where she is also chair of the Global Regulatory Governance and Global Safety Boards and is a member of the Portfolio Investment and Development Review Boards at GSK. She has extensive global industry experience leading teams across regulatory, pharmacovigilance, clinical development, clinical operations, and medical affairs.
Prior to joining GSK, Sabine held senior positions in Medical, Regulatory and Pharmacovigilance with Boehringer Ingelheim, where she established a global epidemiology team and worked across multiple therapeutic areas. Sabine has also been a member of the Biomedical Advisory Council (BMAC) for PhRMA, the Health Section Governing Board for BIO, and the International Council on Harmonisation (ICH) Management Committee on behalf of EFPIA.
Sabine holds a MD from Johannes Gutenberg University (JGU), Mainz, Germany, and an Executive MBA from JGU in cooperation with the McCombs School of Business, University of Texas, Austin. In Germany, she is a licensed physician.